Industry Insights
6 December 2023
Oxford Biomedica Acquires ABL Europe
5 December 2023
Two female pediatric patients with
29 November 2023
FDA investigates T cell malignancy
28 November 2023
Sernova’s Hemophilia A Program Receives Orphan Drug and Rare Pediatric Disease Designations from FDA
Sernova has announced that the
23 November 2023
Clinical results of a gene
22 November 2023
AskBio has announced that the
22 November 2023
IN8bio, Inc. has presented compelling
16 November 2023
The First regulatory authorization of